TOUYUN BIOTECH (01332) Shareholder Transfers Shares from Mingji Securities to CMB Wing Lung Bank, Portfolio Value Reaches HK$26.82 Million
Stock News
Jan 28
According to the latest data from the Hong Kong Stock Exchange, on January 27, a shareholder of TOUYUN BIOTECH (01332) transferred shares from Mingji Securities to CMB Wing Lung Bank, with a portfolio transfer value of HK$26.82 million, accounting for 9.02% of the holdings.
Previously, TOUYUN BIOTECH released its interim results for the six months ended June 30, 2025, revealing that the group generated revenue of HK$36.581 million from sales of goods and services, a decrease of 20.82% year-on-year; profit attributable to company owners was HK$11.243 million, a significant turnaround from a loss of HK$47.969 million in the same period last year; earnings per share stood at 0.4 HK cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.